As we wrap up 2022, we reflect on some of the amazing work accomplished by the consortium over the year:

Collaborative efforts impacted pre-procedure hydration, reduced the number of opioids prescribed to patients, expanded the availability of smoking cessation resources for patients, dramatically improved radiation safety for patients and providers, and increased the prescription of statins at discharge.

Michigan TAVR became the Michigan Structural Heart Consortium (MISHC), and the registry began reporting on transcatheter mitral valve procedures.

Our Best Practice Protocol Task Forces created new documents to guide consortium members through emergencies and more.

This past year also marks the last with Dr. Peter Henke as our Director of Vascular Surgery. For over a decade, Dr. Henke has served as a champion of quality improvement and the registry has thrived under his leadership. We are grateful for all he has contributed in his role as a director and look forward to continued partnership with him as he serves in an ex officio capacity. We will welcome our new Director of Vascular Surgery, Dr. Nicholas Osborne, in January.

We thank you for your dedication to improving quality of care and outcomes for Michigan patients and look forward to continued collaboration in 2023.

The BMC2 Coordinating Center

Support for BMC2 is provided by Blue Cross and Blue Shield of Michigan and Blue Care Network as part of the BCBSM Value Partnerships program.

Although Blue Cross Blue Shield of Michigan and BMC2 work collaboratively, the opinions, beliefs, and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.